Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This year marks the 200th anniversary of the publication of the first codified description of the condition that we now know as Parkinson's disease.

Associate Professor Chrystalina Antoniades from the Nuffield Department of Clinical Neurosicences, and Dr Patrick Lewis from the University of Reading have co-organised the following events to mark the anniversary, together with the Oxford branch of Parkinson's UK.

Exhibition, 11-19 September

The author of the publication describing the condition, James Parkinson, called the disease the Shaking Palsy. Parkinson's talents, however, stretched well beyond neurology. He was a political agitator, general science writer and an influential geologist - all aspects of his work that are showcased in an exhibition from the collections of the Bodleian Library.

Conference, 18 September

This conference for people with Parkinson's, families, friends and healthcare professionals is devised and presented by Parkinson's UK Oxford Branch in collaboration with the University of Oxford's Nuffield Department of Clinical Neurosciences and other leading organisations.

Sessions cover:

  • Progress in research and therapy
  • Sharing best practice
  • Achieving best quality of life

Read more about the conference.

Similar stories

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

New insights gained into how the brain encodes information about the world

Scientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).

Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis

Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.